Diabetic retinopathy is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition can develop in anyone who has type 1 or type 2 diabetes. The longer you have diabetes and the less controlled your blood sugar is, the more likely you are to develop this eye complication.
Source: Mayo Foundation for Medical Education and Research
The TeleEye MD is a mobile enabled technology with fully automated eye screening for mass markets. It is designed to connect screening locations, patients and doctors around the world. This is a telemedicine system for remote diagnosis and patient education where store-and-forward transmission and data archiving could be done with ease. The TeleEye MD enabled with mobile App and fully automated alerts via SMS and App. It has been tested and trailed in multiple clinical environments across Australia and around the world. The DR Lite, Dr Grader and C/D Ratio can be assessed thru TeleEye MD.
DR Lite ™️ diabetic retinopathy screening system is a fast DR “Disease/No Disease” grading system which is easy to assist patient “Referral/No Referral” decision in clinic. The deep learning based DR grading system (DLS) is based on deep learning models. The sensitivity of 97% and specificity of 92% for DR “Disease” Grading. The referral patient will be referred to further human grading or directly to see specialist. The non-referral patients just need to follow regular examination.
The DR Grader ™️ diabetic retinopathy screening system combines an automatic image grading/storage/forward and a long-term retinopathy prediction for patients. The DR Grading approach is based on deep learning models and machine learning models. We are the 1st diabetic retinopathy AI software approved in Singapore and Australia. The consistent performance is over 92%-100% for both “DR disease” sensitivity and specificity. It also provides DR level indications, DR lesion distribution indications and integrates human audition function. Our DR GRADER makes diabetic retinopathy screening possible for primary care providers, diabetes clinics, optical shops and rural clinics to track the patient’s health conditions overtime and identify referable DR patients if necessary.
TeleMedC's portable desktop EyeScan R2 device comprises of a fully automated ophthalmic diagnostic imaging hardware with smart software interface for both anterior and posterior segments for the diagnosis and grading of common eye and chronic illnesses. Our focus is to provide a true low cost imaging device for screening and grading of common eye and chronic illnesses.
The Foot Check APP aims to help the GPs in managing diabetic patients more effectively and gives more power to healthcare nurses in monitoring the health condition of diabetic patients and conducting their periodic foot screening. It is mobile technology enabled with fully automated alerts via SMS and mobile App. this mobile application also helps the patients to manage diabetes more effectively by providing them access to their health records through an electronic health system and allowing them to access their foot screening results conveniently after the completion of foot check.